Literature DB >> 18547516

Preparation of multimilligram quantities of large, linear DNA molecules for structural studies.

Merlind Muecke1, Martin Samuels, Megan Davey, David Jeruzalmi.   

Abstract

We describe a method for preparing large, linear DNA molecules in amounts that are suitable for structural studies. The procedure employs self-primed DNA amplification on a starting molecule that consists of the sequence of interest flanked by the cohesive end sequences from bacteriophage lambda as well as endonuclease recognition sites. Amplification produces long polymers of DNA, tens of kilobases in length, which harbor many copies of the sequence of interest. Endonuclease digestion of these polymers, followed by chromatographic purification, yields high-quality preparations of the DNA molecule of interest. Reliance on the cohesive end sequences to initiate self-primed amplification effectively enables the synthesis of DNA molecules of interest with minimal restriction on length and sequence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547516     DOI: 10.1016/j.str.2008.04.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  4 in total

1.  Crystallization of macromolecules.

Authors:  Troy Messick; Ronen Marmorstein
Journal:  Curr Protoc Protein Sci       Date:  2004-02

2.  Crystallization of macromolecules.

Authors:  David Friedmann; Troy Messick; Ronen Marmorstein
Journal:  Curr Protoc Protein Sci       Date:  2011-11

3.  Biophysical characterization of the centromere-specific nucleosome from budding yeast.

Authors:  Isabel J Kingston; Jasmine S Y Yung; Martin R Singleton
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

4.  Preparation of selective and segmentally labeled single-stranded DNA for NMR by self-primed PCR and asymmetrical endonuclease double digestion.

Authors:  Frank H T Nelissen; Frederic C Girard; Marco Tessari; Hans A Heus; Sybren S Wijmenga
Journal:  Nucleic Acids Res       Date:  2009-06-24       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.